Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avantor Inc. AVTR

Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generat...


Recent & Breaking News (NYSE:AVTR)

Avantor® to Participate in the 5th Annual Evercore ISI HealthCONx Conference

PR Newswire November 15, 2022

Avantor® Continues Investment to Support Biopharma Market with Opening of New Distribution Center in Dublin, Ireland

PR Newswire November 3, 2022

Avantor® Reports Third Quarter 2022 Results

PR Newswire October 28, 2022

Avantor® to Host Third Quarter 2022 Earnings Call on Friday, October 28, 2022

PR Newswire September 29, 2022

Avantor® to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

PR Newswire August 30, 2022

Avantor® Reports Second Quarter 2022 Results

PR Newswire July 28, 2022

Avantor® Names Kitty Sahin Executive Vice President, Strategy and Corporate Development

PR Newswire July 19, 2022

Avantor® to Host Second Quarter 2022 Earnings Call on Friday, July 29, 2022

PR Newswire June 30, 2022

Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers

PR Newswire June 23, 2022

Avantor® to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference

PR Newswire June 1, 2022

Avantor® Releases 2022 Sustainability Report, Highlighting Significant Progress in Environmental, Social and Governance (ESG) Efforts

PR Newswire May 17, 2022

Avantor® Announces Conversion of Mandatory Convertible Preferred Stock

PR Newswire May 13, 2022

Jonathan Peacock Elected Chairman of the Board of Directors of Avantor®

PR Newswire May 12, 2022

Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers

PR Newswire May 10, 2022

Avantor® Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry

PR Newswire May 4, 2022

Avantor® Reports First Quarter 2022 Results

PR Newswire April 28, 2022

Avantor® Declares Dividend on Mandatory Convertible Preferred Stock

PR Newswire April 21, 2022

Avantor® to Report First Quarter 2022 Results and Host Earnings Call on April 29, 2022

PR Newswire April 6, 2022

Avantor® to Participate in KeyBanc Life Sciences and Medtech Investor Forum

PR Newswire March 8, 2022

Avantor® to Participate in Barclays Global Healthcare Conference 2022

PR Newswire March 1, 2022